Literature DB >> 12928073

Recent clinical investigations examining the association of asthma and gastroesophageal reflux.

Susan M Harding1.   

Abstract

For more than a decade, investigations have examined the association between asthma and gastroesophageal reflux (GER), and have demonstrated that the presence of esophageal acid events is associated with respiratory symptoms. The most current research shows that GER is prevalent in patients with asthma, that esophageal acid may alter bronchial hyperresponsiveness, and that medical or surgical GER therapy may improve asthma outcome in selected asthma patients. Further research will build on our current knowledge base and, hopefully, enable us to better identify those patients with asthma who will most benefit from reflux therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928073     DOI: 10.1016/s0002-9343(03)00191-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Authors:  Leonardo M Del Grande; Fernando A M Herbella; Amilcar M Bigatao; Henrique Abrao; Jose R Jardim; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2015-09-24       Impact factor: 3.452

Review 2.  Atypical manifestations of gastroesophageal reflux disease.

Authors:  Michael F Vaezi
Journal:  MedGenMed       Date:  2005-10-27

3.  Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (GERD).

Authors:  Leonardo M Del Grande; Fernando A M Herbella; Amilcar M Bigatao; Jose R Jardim; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2016-06-27       Impact factor: 3.452

Review 4.  Upper aerodigestive tract disorders and gastro-oesophageal reflux disease.

Authors:  Andrea Ciorba; Chiara Bianchini; Michele Zuolo; Carlo Vittorio Feo
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

5.  Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.

Authors:  Maria Pina Dore; Antonietta Pedroni; Gianni M Pes; Emanouil Maragkoudakis; Vincenza Tadeu; Pietro Pirina; Giuseppe Realdi; Giuseppe Delitala; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

6.  The effects of volatile salivary acids and bases on exhaled breath condensate pH.

Authors:  Richard M Effros; Richard Casaburi; Jennifer Su; Marshall Dunning; John Torday; Julie Biller; Reza Shaker
Journal:  Am J Respir Crit Care Med       Date:  2005-11-10       Impact factor: 21.405

Review 7.  Extraoesophageal manifestations of gastro-oesophageal reflux.

Authors:  J Poelmans; J Tack
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 8.  Esophageal impedance monitoring for gastroesophageal reflux.

Authors:  Hayat M Mousa; Rachel Rosen; Frederick W Woodley; Marina Orsi; Daneila Armas; Christophe Faure; John Fortunato; Judith O'connor; Beth Skaggs; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-02       Impact factor: 2.839

9.  Guidance on the diagnosis and management of asthma among adults in resource limited settings.

Authors:  Bruce J Kirenga; Jeremy I Schwartz; Corina de Jong; Thys van der Molen; Martin Okot-Nwang
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.